Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Sio Gene Therapies Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +1 vs. Q1 2022
- Shares held
- 20.7M
- +2.58M (+14.2%) vs. Q1 2022
- Total value
- $7.44M
- −$4.69M (−38.6%) vs. Q1 2022
- New holders
- 8
- 5 more added
- Sold out
- 7
- 14 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SIOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $26.0K |
| Q1 2023 | 4 | $1.13M |
| Q4 2022 | 37 | $8.09M |
| Q3 2022 | 38 | $5.91M |
| Q2 2022 | 41 | $7.44M |
| Q1 2022 | 40 | $12.1M |
| Q4 2021 | 48 | $27.6M |
| Q3 2021 | 55 | $39.9M |
| Q2 2021 | 53 | $56.1M |
| Q1 2021 | 55 | $53.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Sio Gene Therapies Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 37 | $0 | 0.00% | −26,875−99.9% | Reduced |
| Bank of America Corp | 114 | $0 | 0.00% | −8,352−98.7% | Reduced |
| Group One Trading, L.P. | 916 | $0 | 0.00% | −2,048−69.1% | Reduced |
| Captrust Financial Advisors | 1,018 | $0 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 360 | $0 | 0.00% | +23+6.8% | Added |
| The PNC Financial Services Group, Inc. | 125 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 179 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 700 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 86 | $0 | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 400 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 1,305 | $0 | 0.00% | +1,305 | New |
| Morgan Stanley | 12,381 | $4.00K | 0.00% | −4,873−28.2% | Reduced |
| Primecap Management Co | 16,700 | $6.00K | 0.00% | −1,600−8.7% | Reduced |
| Merit Financial Group, LLC | 17,750 | $6.00K | 0.00% | +17,750 | New |
| Dimensional Fund Advisors LP | 20,749 | $7.00K | 0.00% | −169,921−89.1% | Reduced |
| Verition Fund Management LLC | 20,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 23,028 | $8.00K | 0.00% | +23,028 | New |
| Boothbay Fund Management, LLC | 30,000 | $11.0K | 0.00% | +30,000 | New |
| Tower Research Capital LLC (TRC) | 35,014 | $13.0K | 0.00% | +26,752+323.8% | Added |
| Franklin Resources Inc | 55,570 | $20.0K | 0.00% | −26,552−32.3% | Reduced |
| Susquehanna International Group, LLP | 57,187 | $20.0K | 0.00% | −4,546−7.4% | Reduced |
| UBS Group AG | 55,529 | $20.0K | 0.00% | +55,529 | New |
| Macquarie Group Ltd | 64,170 | $23.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 71,025 | $26.0K | 0.00% | −24,421−25.6% | Reduced |
| Northern Trust Corp | 87,153 | $31.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 92,445 | $33.0K | 0.00% | +92,445 | New |
| ACT Capital Management, LLC | 146,500 | $53.0K | 0.07% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 155,400 | $56.0K | 0.00% | −89,500−36.5% | Reduced |
| State Street Corp | 173,621 | $63.0K | 0.00% | +6,500+3.9% | Added |
| BlackRock Inc. | 390,386 | $141.0K | 0.00% | −133,737−25.5% | Reduced |
| Clearline Capital LP | 392,691 | $141.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 433,386 | $156.0K | 0.00% | +2,178+0.5% | Added |
| Renaissance Technologies LLC | 460,394 | $166.0K | 0.00% | −106,759−18.8% | Reduced |
| Cladis Investment Advisory, LLC | 737,000 | $265.5K | 0.27% | −509,000−40.9% | Reduced |
| Newtyn Management, LLC | 1,415,859 | $510.0K | 0.10% | +1,415,859 | New |
| Hudson Bay Capital Management LP | 1,680,536 | $605.0K | 0.01% | −1,464−0.1% | Reduced |
| Vanguard Group Inc | 2,098,581 | $756.0K | 0.00% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 5,914,000 | $2.13M | 0.08% | 00.0% | Unchanged |
| Rubric Capital Management LP | 6,011,005 | $2.17M | 0.11% | +3,011,005+100.4% | Added |
| Tower View Investment Management & Research LLC | 11,653 | – | – | +11,653 | New |
| Prosight Management, LP | 0 | $0 | 0.00% | −670,300−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −208,065−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −55,838−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −49,528−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,918−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −312−100.0% | Sold out |